Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non–small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non–small cell lung cancer

Published:2019-12 Issue:6 Volume:158 Page:1680-1692.e2
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Raman Vignesh,Jawitz Oliver K.,Yang Chi-Fu J.,Voigt Soraya L.,Wang Hanghang,D'Amico Thomas A.,Harpole David H.,Tong Betty C.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference23 articles.

1. National Comprehensive Cancer Network (NCCN) guidelines on treatment of small cell lung cancer;National Comprehensive Cancer Network,2018

2. Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer;DeCamp;J Thorac Cardiovasc Surg,2003

3. Induction chemoradiotherapy and surgical resection for selected stage IIIB non–small-cell lung cancer;Ichinose;Ann Thorac Surg,2003

4. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial;Stupp;Lancet Oncol,2009

5. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non–small cell lung cancer;Grunenwald;J Thorac Cardiovasc Surg,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying optimal surgical approach among T1N2–3M0 non-small cell lung cancer patients: a population-based analysis;Translational Lung Cancer Research;2024-04

2. Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort study;BJS Open;2024-03-01

3. Neoadjuvant savolitinib targeted therapy for stage IIIB-N3 lung adenocarcinoma harboring mesenchymal–epithelial transition exon 14 skipping mutation: a case report and literature review;Anti-Cancer Drugs;2024-02-23

4. Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study;Nature Communications;2023-08-03

5. Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact;Cancers;2023-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3